A prospective study of HLA*B-5801 genotyping in preventing allopurinol- induced severe cutaneous adverse reactions

A prospective study of HLA*B-5801 genotyping in preventing allopurinol- induced severe cutaneous adverse reactions

Bibliographic Details
Main Authors:	Ko, Tai-Ming, Wu, Jer-Yuarn, Chen, Yuan-Tsong, Shen, Chen-Yang
Format:	Online
Language:	English
Published:	BioMed Central 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128421/

Similar Items

Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study
by: Ko, Tai-Ming, et al.
Published: (2015)

HLA-B*58:01 allele is strongly associated with allopurinol-induced severe cutaneous adverse reactions in a Thai population
by: Jantararoungtong, Thawinee, et al.
Published: (2014)

Cost-Effectiveness Analysis of HLA-B*5801 Testing in Preventing Allopurinol-Induced SJS/TEN in Thai Population
by: Saokaew, Surasak, et al.
Published: (2014)

Safety and efficacy of oral febuxostat for treatment of HLA-B*5801-negative gout: a randomized, open-label, multicentre, allopurinol-controlled study
by: Yu, K-H, et al.
Published: (2016)

HLA-B*58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand
by: Sukasem, Chonlaphat, et al.
Published: (2016)

Validation of a Rapid, Robust, Inexpensive Screening Method for Detecting the HLA-B*58:01 Allele in the Prevention of Allopurinol-Induced Severe Cutaneous Adverse Reactions
by: Nguyen, Dinh Van, et al.
Published: (2017)

Association of HLA-B*5801 allele and allopurinol-induced stevens johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis
by: Somkrua, Ratchadaporn, et al.
Published: (2011)

Crystal structure of HLA-B*5801, a protective HLA allele for HIV-1 infection
by: Li, Xiaolong, et al.
Published: (2016)

Association between HLA-B* 15:02 and carbamazepine induced severe cutaneous adverse drug reactions in Myanmar
by: Husna Zayadi
Published: (2017)

HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese
by: Nguyen, Dinh Van, et al.
Published: (2015)

Adverse cutaneous drug reactions
by: Adibi, Neda
Published: (2014)

Cutaneous Adverse Reactions of Amiodarone
by: Jaworski, Krzysztof, et al.
Published: (2014)

Risk factors of mortality in severe cutaneous adverse reactions patients with pulmonary involvement
by: Hu, H, et al.
Published: (2012)

Cytotoxic Proteins and Therapeutic Targets in Severe Cutaneous Adverse Reactions
by: Su, Shih-Chi, et al.
Published: (2014)

Recent advances of pharmacogenomics in severe cutaneous adverse reactions: immune and nonimmune mechanisms
by: Dao, Ro-Lan, et al.
Published: (2015)

Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation
by: Su, Shih-Chi, et al.
Published: (2016)

Severe Cutaneous Adverse Drug Reactions: A Clinicoepidemiological Study
by: Sasidharanpillai, Sarita, et al.
Published: (2015)

Analysis of B cell subsets in severe cutaneous adverse reaction
by: Azukizawa, Hiroaki, et al.
Published: (2014)

Multiple drug hypersensitivity associated with severe cutaneous adverse reaction
by: Lin Choo, Karen Jui, et al.
Published: (2014)

Predicting HLA genotypes using unphased and flanking single-nucleotide polymorphisms in Han Chinese population
by: Hsieh, Ai-Ru, et al.
Published: (2014)

Causality Assessment of Cutaneous Adverse Drug Reactions
by: Son, Young-Min, et al.
Published: (2011)

Vancomycin-Associated Spontaneous Cutaneous Adverse Drug Reactions
by: An, So-Yeon, et al.
Published: (2011)

Cutaneous adverse drug reactions induced by Oxcarbazepine
by: Hsiao, Yi-Hsin, et al.
Published: (2014)

Real-World Efficiency of Pharmacogenetic Screening for Carbamazepine-Induced Severe Cutaneous Adverse Reactions
by: Chen, Zhibin, et al.
Published: (2014)

The Pharmacogenomic HLA Biomarker Associated to Adverse Abacavir Reactions: Comparative Analysis of Different Genotyping Methods
by: Stocchi, Laura, et al.
Published: (2012)

Development of spectrophotometric method for allopurinol in urine based on the diazotization reaction
by: Nor Fathihah binti Mamat
Published: (2014)

Allopurinol-induced DRESS syndrome
by: Yaylacı, Selcuk, et al.
Published: (2012)

Allopurinol induced erythroderma
by: Sharma, Geeta, et al.
Published: (2013)

Transient hypofibrinogenemia due to allopurinol
by: Yin, ZhiQiang, et al.
Published: (2014)

Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations
by: González-Galarza, Faviel F., et al.
Published: (2015)

A Clinical Study of Cutaneous Adverse Reactions to Nonionic Contrast Media in Korea
by: Jung, Kyung Eun, et al.
Published: (2012)

Cutaneous Adverse Reactions to Highly Antiretroviral Therapy in HIV-Positive Patients
by: Pistone, G., et al.
Published: (2014)

Probable cutaneous adverse drug reaction to piroxicam in a cat
by: Amanda J Young, et al.
Published: (2018-07-01)

Cutaneous adverse reactions specific to epidermal growth factor receptor inhibitors
by: Lupu, I, et al.
Published: (2015)

Cutaneous adverse drug reaction type erythema multiforme major induced by eslicarbazepine
by: Massot, Andreu, et al.
Published: (2014)

Adverse cutaneous drug reactions: Eight year assessment in hospitalized patients
by: Mokhtari, Fatemeh, et al.
Published: (2014)

Cutaneous adverse drug reactions in Indian population: A systematic review
by: Patel, Tejas K, et al.
Published: (2014)

Patch testing in drug cutaneous adverse reactions: value of the extemporaneous preparations
by: Assier, Haudrey, et al.
Published: (2014)

Cutaneous Adverse Drug Reactions in Dogs Treated with Antiepileptic Drugs
by: Koch, Tina, et al.
Published: (2016)

Mechanisms that limit proliferative potential of drug-specific LTT in drug-induced severe cutaneous adverse reaction patients
by: Valeyrie-Allanore, Laurence, et al.
Published: (2014)